Shares of Oxford Industries sank after hours Wednesday after the maker of Tommy Bahama and Lilly Pulitzer clothing cut its ...

Lily Collins attended the opening for the musical rendition of the film "The Devil Wears Prada" held at the Dominion Theatre ...

Telehealth firm Ro has partnered with Eli Lilly And Co (NYSE:LLY) to enhance patient access to Zepbound (tirzepatide) single-dose vials for obesity treatment. Through LillyDirect, Ro will provide ...

Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 EMBER-3 study of imlunestrant, an investigational, oral selective estrogen receptor degrader (SERD), in patients with ...

Eli Lilly and Novo Nordisk dominate the market for weight loss drugs, and demand for their products has surpassed supply in recent times. Lilly’s weight loss portfolio has already delivered ...

Position the ball ornaments and any other tree decorations, including the Christmas bells, where you’d like them to be on ...

Eli Lilly said its weight loss drug Zepbound led to 47% greater weight reduction than rival medicine Wegovy, made by Novo Nordisk, in a head-to-head randomized controlled trial. The result ...

One of Eli Lilly's potential competitors in the weight loss market just reported unimpressive trial results. The company could benefit from the government coverage of its weight loss medicines.

Release Inc aims to give gifts to 1,000 foster kids and offers ongoing mental health support and clothing resources. All ...

Lily Collins has grown up in front of the public eye and in that time, she has transformed into a fashion darling. The ...

Oxford Industries expects full-year earnings in the range of $6.50 to $6.70 per share, with revenue ranging from $1.5 billion to $1.52 billion. This story was generated by Automated Insights ( ...